Neuroinflammation-mediated YKL-40 correlates with tau pathology and predicts longitudinal cognitive impairment and brain atrophy in Alzheimer’s disease, with hypertensive dependency. The gene discussed is MAPT; the disease is early-onset autosomal dominant Alzheimer disease.